MIMOSA Diagnostics Inc., (MIMOSA) founded by Dr. Karen Cross and Dr. General Leung, has developed a portable, light-based imaging technology that transforms skin health assessments. MIMOSA Pro consists of a small cellphone sized device and a connected care platform to enable physicians to manage patients remotely. The COVID-19 pandemic has overwhelmed healthcare systems globally, and non-emergent patients have been unable to receive routine physical care, which is resulting in an increase in amputations and mortality. Moreover, a billion people lack access to healthcare globally - MIMOSA is committed to breaking down geographical and socio-economic barriers to increase access to healthcare. This small and mighty MIMOSA Pro device allows for equal access to specialized healthcare for all.